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Abstract
The inability of the avascular region of the meniscus to regenerate has led to the use of tissue engineering to treat
meniscal injuries. The aim of this study was to evaluate the ability of fibrochondrocytes preseeded on PLDLA/
PCL-T [poly(L-co-D,L-lactic acid)/poly(caprolactone-triol)] scaffolds to stimulate regeneration of the whole
meniscus. Porous PLDLA/PCL-T (90/10) scaffolds were obtained by solvent casting and particulate leaching.
Compressive modulus of 9.5 – 1.0MPa and maximum stress of 4.7 – 0.9MPa were evaluated. Fibrochondrocytes
from rabbit menisci were isolated, seeded directly on the scaffolds, and cultured for 21 days. New Zealand rabbits
underwent total meniscectomy, after which implants consisting of cell-free scaffolds or cell-seeded scaffolds were
introduced into the medial knee meniscus; the negative control group consisted of rabbits that received no im-
plant. Macroscopic and histological evaluations of the neomeniscus were performed 12 and 24 weeks after im-
plantation. The polymer scaffold implants adapted well to surrounding tissues, without apparent rejection,
infection, or chronic inflammatory response. Fibrocartilaginous tissue with mature collagen fibers was observed
predominantly in implants with seeded scaffolds compared to cell-free implants after 24 weeks. Similar results
were not observed in the control group. Articular cartilage was preserved in the polymeric implants and showed
higher chondrocyte cell number than the control group. These findings show that the PLDLA/PCL-T 90/10
scaffold has potential for orthopedic applications since this material allowed the formation of fibrocartilaginous
tissue, a structure of crucial importance for repairing injuries to joints, including replacement of the meniscus and
the protection of articular cartilage from degeneration.
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Introduction
Leisure activities, sports activities, and certain workconditions are frequently associated with accidental tis-
sue injury.1 Of particular concern are knee injuries that affect
the meniscus of the joint. The knee menisci are semilunar-
shaped fibrocartilagenous structures interposed between the
femoral condyle and tibial plateau and are essential for
proper performance of the knee joint.2 The functions of the
meniscus include body weight distribution, pressure resis-
tance, shock absorption, the lubrication and adjustment to
tibial surfaces, modulation of femoral condyle shape, and
joint stabilization during flexion and extension.3 These func-
tions, which are essential for joint protection and the preven-
tion of injuries and osteoarthritis, are guaranteed by the
specific organization of the extracellular matrix cells of this
tissue.4
The susceptibility of this tissue to injury and its limited re-
generative capacity have led to different strategies aimed at
restoring meniscus function.5 The use of natural autologous
materials for this purpose has yielded unsatisfactory results
because of unfavorable mechanical properties and the diffi-
culty in obtaining these natural substitutes.6–8 With regard
to the use of prostheses, there are still no artificial materials
with mechanical properties similar to those of the original
meniscus.9 Although nonabsorbable synthetic materials
allow cell invasion, collagen I and II deposition, and the for-
mation of new tissue with fibrochondrocyte-like characteris-
tics,10 they are unable to confer long-term protection to
articular cartilage after long periods.11
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Given these difficulties, the use of hydrolytically degradable
polymers to regenerate the meniscus has been extensively
studied.12–14 The biodegradability and bioreabsorption charac-
teristics of poly(a-hydroxy acids)15 make this polymer a prom-
ising option for tissue regeneration and have led to this
compound’s widespread use for biomedical purposes, particu-
larly because of its biocompatibility.16
The copolymer PLDLA [poly(L-co-D,L-lactic acid)] has
similar mechanical properties to poly(lactic acid) without
the long degradation time associated with this homopoly-
mer due to the greater degradation of poly(D,L lactic
acid).17 The addition of low molecular weight molecules
such as PCL-T [poly(caprolactone-triol)] to PLDLA yields a
more hydrophilic polymer with greater chain mobility and
results in characteristics that enhance interaction with cells
and tissues.18
Cell cultivation on polymer substrates and subsequent im-
plantation can improve the healing process in cartilage inju-
ries when efficient materials such as bioreabsorbable fiber
polymers and other porous structures are used.19–23 How-
ever, the usefulness of coculture on PLDLA/PCL-T for menis-
cus regeneration following medial meniscectomy has not
been investigated, and the ideal cell type for such use has
not been determined. Autologous and allogeneic meniscus
cells, articular chondrocytes, fibrochondrocytes, fibroblasts,
and mesenchymal stem cells represent possible sources of
cells for such regeneration.24
The aim of this study was therefore to assess the usefulness
of primary cultures of rabbit meniscus fibrochondrocytes
grown on PLDLA/PCL-T (90/10) scaffolds for meniscus re-
generation. Specifically, we examined the allogeneic cultiva-
tion of these cells and the influence of this material on
tissue regeneration and its effects on degeneration of the artic-
ular cartilage of the medial femoral condyle in vivo.
Materials and Methods
Preparation of polymeric scaffolds
PLDLA (70:30) was synthesized in the Laboratory of Bio-
materials (Pontifical Catholic University of Sao Paulo [PUC-
SP]), MW 265.028 g/mol Poly(caprolactone triol, PCL-T)
was supplied by Solvay (CAPA 3091), MW 900g/mol.
Solutions of PLDLA/PCL-T (90/10, w/w) were prepared
by diluting the polymer in chloroform (Merck) to a final
concentration of 10% (w/v) at 25C. After complete polymer
dissolution, 50% (w/v) sucrose (Synth) was added and the
granulometry was maintained at 250–500 lm. The solutions
were poured into silicone molds of the same dimensions as
the rabbit menisci. After solvent evaporation and removal
of the sucrose in polyvinyl alcohol, the scaffolds were dis-
infected with 70% ethanol overnight and sterilized by UV
radiation.
Compression tests
Compression tests were done on cylindrical PLDLA/PCL-
T scaffolds (diameter of 5.0mm; height of 6.0mm) at 1mm/
min up to a strain level of 0.7mm/mm (70%). All of the
tests were done on three-dimensional scaffolds in a dry
state using an INSTRON 5566 testing machine. The compres-
sive modulus was calculated as the slope of the initial linear
region of the stress–strain curve.
Isolation of rabbit meniscus fibrochondrocytes
Fibrochondrocytes were isolated from a pool of menisci
(n= 16) essentially as described by Figueiredo and Joazeiro.25
Four male New Zealand white rabbits (*90 days old) were
sacrificed. The fibrocartilages were removed by sectioning
the joint capsule and the medial and lateral menisci of both
legs were collected and placed in Dulbecco’s modified Eagle’s
medium (DMEM; Cultilab) containing gentamicin (Sigma,
50mg/L) and amphotericin B (Sigma, 2.5mg/L). In a sterile
environment, the fibrocartilages were fragmented and sub-
jected to enzymatic digestion (3 h at 37C) in DMEM supple-
mented with 1mg of type IA collagenase/mL (Sigma). The
cell suspension was then centrifuged (216 g, three times,
5min) and the pellet resuspended in DMEM supplemented
with 10% fetal calf serum (FCS). Cell viability was assessed
by the Trypan blue exclusion test. The fibrochondrocytes
(*106 cells/mL) were seeded directly onto the scaffolds in
DMEM 10% FCS and incubated at 37C in a humidified atmo-
sphere containing 5% CO2. The cells were allowed to adhere
and proliferate for 21 days.
Surgical technique and scaffold implantation
All of the procedures involving animals described in this
study were approved by the Ethics Committee in Animal
Research at the Universidade do Vale do Paraı´ba (UNIVAP;
protocol no. UNIVAP A047/CEP/2009). Twenty-four New
Zealand white rabbits (150 days old, both sexes) were used
essentially as described by Cardoso et al.14 The rabbits were
anesthetized with ketamine hydrochloride (35mg/kg, intra-
muscular [IM]) and xylazine hydrochloride (5mg/kg, IM)
and then positioned on an operating table in supine position.
A medial longitudinal parapatellar incision (*5 cm long)
was followed by dissection of the subcutaneous tissue, me-
dial parapatellar capsulotomy, lateral dislocation of the
knee extensor (quadriceps and patellar tendon), sectioning
of the medial collateral ligament in the joint line, and careful
in toto resection of the medial meniscus, without damaging
the medial femoral condyle articular cartilage; this was fol-
lowed by scaffold implantation (Fig. 1).
FIG. 1. Surgical procedure for implanting cell-free scaffolds
and scaffolds preseeded with fibrochondrocytes. The medial
parapatellar approach was used for meniscectomy and im-
plant insertion.
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The implant was fixed with monofilament 5-0 nylon su-
ture, with two stitches (one anterior and another peripherally)
in the middle portion of the device. The suture involved the
polymeric scaffold and the perimeniscal capsular tissues.
After implantation, separate stitches with nylon suture 4-0
were used for the capsule and medial collateral ligament re-
pair and continuous sutures for the skin. The postoperative
bandage consisted of sterile gauze. The animals were placed
in individual suspended cages immediately after surgery and
received food and water ad libitum.
Groups
The rabbits underwent total meniscectomy in both knees
joints, right leg and left leg, totaling two medial menisci per
animal. Twelve and 24 weeks indicating the number of
weeks between surgery and euthanasia. The rabbits were di-
vided into three groups of four animals (n = 8 medial menisci)
each. In group A, rabbits received an allogeneic implant; i.e., a
scaffold seeded with fibrochondrocytes obtained from other
conspecific individuals. In group B, the rabbits received a
cell-free polymeric implant (pure PLDLA/PCL-T scaffold).
The third group was the negative controls, in which menis-
cectomy was done in both legs (right and left) via a medial
parapatellar incision, without any subsequent implant
(empty defect). With this it is possible to analyze the condi-
tions of the femoral condyle without the presence of the me-
niscus as it occurs in menisectomia procedures.
For comparison with the treatments, a positive control
group (three rabbits, n = 6 condyles) with no surgical inter-
vention or scaffold implant was used to obtain normal me-
nisci and condyles for histological and histomorphometric
analysis.
Tissue sampling and processing for histological analysis
Twelve and 24 weeks after surgery the ‘‘neomenisci’’ were
removed via a medial parapatellar incision (device and sur-
rounding tissue) and the respective medial femoral condyles
of both knees were collected. The tissues were photographed
and then immediately placed in Bouin and fixed for 24h.
The condyles were decalcified for 14 days in an EDTA decalci-
fying solution.
The samples were subsequently processed for histologi-
cal analysis and embedded in paraffin or historesin. Five-
micrometer-thick sections were cut on a microtome (Leica
RM2245) and stained with hematoxylin and eosin (HE),
Masson’s trichrome (MT), and Picrossirus red and were ex-
amined under polarized light (Eclipse E800 microscope,
Nikon). For tissue included in historesin, 2-lm-thick sec-
tions were stained with 0.1% toluidine blue (TB) in 1% borax.
Histomorphometric analysis of the condyles
Sections from condyles were examined and photographed
(Eclipse E800 microscope, Nikon), and the number of chon-
drocytes in the hyaline cartilage was quantified with NIS soft-
ware from Elements Advanced Research. Five fields per
sections were examined using a 40 · objective (total area:
0.63mm2) and eight slides were examined per treatment
(total area, 25.20mm2; n= 40 per treatment). The results for
the different groups were compared using ANOVA followed
by the Tukey test, with p< 0.01 indicating significance.
Results
In this study, we examined the tissue repair after total
meniscectomy of the medial meniscus in rabbits treated
with a combination of bioreabsorbable material and allogenic
fibrochondrocytes.
The mechanical performance of the PLDLA/PCL-T scaf-
folds was assessed through compression tests. The stress–
strain curves showed a linear region, which was well evident
at low values of strain and thus highlighted an initial stiff me-
chanical response. This region was followed by a region with
lower stiffness and finally another stiff portion of the stress–
strain curve (Fig. 2A). Figure 2B shows the mechanical behav-
ior up to a strain level of 0.06mm/mm (6%).
These results were similar to those of flexible foams and
rapid prototyped PCL scaffolds.26 A compressive modulus
of 9.5 – 1.0MPa (mean value – standard deviation) was calcu-
lated as the slope of the linear region of the stress–strain
curve. The behavior was initially linear up to a strain of
0.003mm/mm (0.3%). A maximum stress of 4.7 – 0.9MPa
was also evaluated at a strain value of 0.7mm/mm (70%).
We compared regeneration using implants of cell-free
PLDLA/PCL-T scaffolds and of PLDLA/PCL-T scaffolds
preseeded with fibrochondrocytes. The scaffold dimensions
were unaltered for 21 days by culture with fibrochondrocytes.
All of the treated rabbits survived until euthanasia and
FIG. 2. (A) Typical stress–
strain curve obtained for
cylindrical PLDLA/PCL-T
scaffolds compressed at a rate
of 1mm/min up to a strain
level of 0.7mm/mm (70%).
(B) Typical stress–strain curve
obtained for cylindrical
PLDLA/PCL-T scaffolds up
to a strain level of 0.06mm/
mm, showing the initial linear
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showed similar behavior (normal agility and movements) to
that of nonoperated rabbits. There were no postsurgical com-
plications.
Macroscopic evaluation showed that all rabbits had com-
plete healing of the incision, with no external scar (Fig. 3A).
There were no clinical differences between cell-free and cell-
seeded implants.
On withdrawal, the implanted scaffolds were found to be
well adapted to the surrounding tissues, with no apparent re-
jection, infection, or chronic inflammatory response (Fig. 3B).
In seven of eight control rabbits, the presence of fibrous tissue
connecting the femoral condyle to the tibial plateau was ob-
served (Fig. 3C). This tissue was also found inside the defect,
although most of it was empty or partially filled with adipose
tissue.
After 12 and 24 weeks, the neotissue that formed around
the polymer scaffold implants retained its biological features,
regardless of whether the scaffolds had been seeded with
fibrochondrocytes or not. Highlighting the results after 24
weeks, neomenisci formed from the seeded PLDLA/PCL-T
scaffold showed anatomical features similar to those of nor-
mal (biological) menisci (Fig. 3B). This was not observed in
control rabbits since the newly formed tissue was fixed to
the tibial plateau in the posterior region and did not fill the
entire area formerly occupied by the meniscus.
Morphology of normal menisci and condyles
Figure 4 shows the histomorphological characteristics of
the normal medial meniscus and condyle of rabbits. The
outer zone of the meniscus and the horns (tips) consisted
mainly of thin circumferentially oriented collagen fibers and
also some radially oriented fibers, both with only a few elon-
gated cells similar to those of fibrous tissue (Fig. 4A). More in-
ternally, corresponding to the central portion of the meniscus,
there were numerous fibrochondrocytes with a round mor-
phology, as well as axial isogenic groups permeated by a
collagen matrix usually with parallel lines (Fig. 4B). These fea-
tures are characteristic of fibrous cartilage (fibrocartilage),
which has a thicker, more abundant matrix that is richer in
collagen type I compared to hyaline cartilage.
The term fibrochondrocytes was introduced in 1985 to de-
scribe the peculiar characteristics of this population of cells in
joint tissue.27 The fibrochondrocytes inside the meniscus are
round or oval and are located in the avascular area; these
cells are strongly associated with the matrix and an intense
presence of pericellular proteoglycans. Fibroblasts are located
in the peripheral region of the meniscus (vascular portion).28
A third type of cell in the meniscus consists of slightly spin-
dle-shaped cells referred to as ‘‘cells of the superficial zone
of the meniscus’’.29 These cells have no cytoplasmic exten-
sions.29
The biological knee joint, i.e., one with a normal natural
meniscus and no surgical intervention, served as a positive
control for the femoral condyle. Comparison between this
joint and the operated joints makes it possible to determine
the morphological changes in response to the polymeric ma-
terial with and without associated cells.
Large quantities of well-organized hyaline cartilage popu-
lated by chondrocytes were observed in all areas of the joint
(Fig. 4C). In addition, cell morphology and density, collagen
fiber concentration, diameter and orientation, water concen-
tration, and the presence of glycosaminoglycans vary with
the depth of the joint layer. Based on variations in these char-
acteristics, articular cartilage can be divided into superficial,
middle, deep, and calcified cartilage zones.30
The complex organization of each of these zones and the
interaction between extracellular matrix components and
the solid and liquid components of articular cartilage are di-
rectly related to the biomechanical function of the joint.31
Twelve weeks after implantation
Figure 4D–4F shows photomicrographs of knee joints after
the implantation of cell-free PLDLA/PCL-T scaffolds. In all
cases there was a foreign body granulomatous reaction that
consisted of giant and mononuclear cells along with polymer
fragments, indicating that the material had not yet been com-
pletely degraded (Fig. 4D). This reaction was also observed
around the suture site. Blood vessels and adipose tissue
were also detected. The presence of blood vessels indicating
good irrigation in the newly formed conjunctive tissue was
FIG. 3. Macroscopic ap-
pearance of the knee joint
during the removal of im-
plants after 24 weeks. (A)
Shaved surface of the oper-
ated region showing complete
healing of the epithelial tissue
with no external scar. Similar
healing was seen in all treat-
ments. (B) Cell-seeded im-
plant showing a medial
‘‘neomeniscus’’ (arrow) with
similar morphology to the bi-
ological meniscus. (C)Control
knee-joint: note the presence
of lateral fibrosis (arrow)
connecting the femoral con-
dyle to the tibial plateau.
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an important feature for the inflammatory response, the mi-
gration of mesenchymal cells, nutrition, and consequent tis-
sue regeneration. The presence of fibrocartilage-like tissue
was also noted (Fig. 4E). Areas with this type of tissue
showed no vascularization since a low level of oxygen is a
key factor for fibrochondrocyte differentiation.32 Staining
with MT revealed dense collagen arranged in fibers (data
not shown). Histological analysis of the condyle showed an
abundance of chondrocyte-like cells and early disruption of
the upper superficial layer (Fig. 4F).
FIG. 4. Twelve weeks after implantation. Scale bar = 100 lm unless otherwise indicated. (A–C) Photomicrograph of normal
rabbit medial meniscus and condyle. (A) The horn (tip) of the meniscus consisted mainly of thin circumferentially oriented
collagen fibers and a few elongated cells; hematoxylin and eosin (HE). (B) Central region of the meniscus showing numerous
round fibrochondrocytes surrounded by collagen fibers; HE. (C) A normal femoral condyle (positive control) showing the or-
ganization of the extracellular matrix and the presence of chondrocytes throughout the cartilage; HE, scale bar = 200lm. (D–F)
Photomicrographs of knee joints after receiving cell-free implants. (D) Fibrocartilage-like area; HE. (E) A foreign body gran-
ulomatous reaction around polymer fragments (arrow); toluidine blue (TB). (F) A femoral condyle with a large number of
chondrocytes embedded in the tissue; HE. (G–I) Photomicrographs of knee joints after receiving cell-seeded implants. (G)
Fibrocartilage-like tissue at the extremities; HE. (H) Central region of neotissue showing cells arranged in line to resemble iso-
morphic groups; HE, scale bar = 50lm. (I)A femoral condyle with chondrocytes at the articular surface. HE. ( J–L) Photomicro-
graphs of negative control knee joints (empty defect) after total medial meniscectomy. ( J) Presence of adipocytes and blood
capillaries within the newly formed connective tissue. Small areas of fibrocartilage-like tissue; HE. (K) Large area of fat depos-
its and blood capillaries within the neotissue. Masson’s trichrome (MT). (L) A femoral condyle showing disorganization and
the presence of a few chondrocytes. Note the discontinuity with early joint degeneration; HE, scale bar = 200 lm.
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In cell-seeded implants, a fibrocartilage-like tissue resem-
bling that of a normal meniscus was observed (Fig. 4G);
this tissue contained more fibrochondrocyte-like cells than
did cell-free implants. Likewise, there was evidence of giant
cell reactions in response to a foreign body. The arrangement
of cells in line to resemble isomorphic groups (Fig. 4H) sug-
gested recent fibrocartilage formation. Metachromasia was
observed in images of TB-stained sections obtained from tis-
sue embedded in historesin (data not shown). The change in
dye color from blue to pink reflected the presence of sulfated
glycosaminoglycans, a feature of fibrocartilage. According to
Angele et al.33 metachromasia in the extracellular matrix is
most pronounced between the anterior horn and the pars
intermedia of the meniscus, which contains mainly type II
collagen and glycosaminoglycans, and distinguishes this re-
gion from the outer zone and posterior region. Histological
examination of the condyles revealed an extracellular matrix
containing embedded chondrocytes and no signs of cell dis-
ruption (Fig. 4I).
In the control group, adipose tissue and numerous blood
capillaries were observed within the newly formed tissue
(Fig. 4K). Small central areas of fibrocartilage-like tissue
with few cells embedded in the matrix were also observed
(Fig. 4J); there was no foreign inflammatory reaction since
these control joints had received no implants. Condyle histo-
logical examination revealed a less organized extracellular
matrix and cell disruption, with chondrocytes being present
in only a few of the upper (outer) layers (Fig. 4L). The onset
of cartilage loss and morphological alterations in the matrix
were also observed.
Twenty-four weeks after implantation
After 24 weeks, joints that received cell-free implants con-
tained fibrocartilage-like tissue with disorganized fibrochon-
drocytes-like cells and irregularly arranged collagen fibers.
The synovium had a delicate, vascular appearance and was
easily recognized. There were peripheral blood capillaries, a
small amount of hyaline cartilage with a basophilic stroma
and fibrochondrocytes that were either solitary or arranged
in isogenous groups of two cells (Fig. 5D); metachromasia
was also observed (Fig. 5E), as were foreign body granuloma-
tous reactions and peripherally located adipocytes. The con-
dyles contained numerous chondrocytes, although in some
regions it can be seen that the extracellular matrix has small
areas of the joint surface irregularities (Fig. 5F).
In joints that received preseeded implants, the fibrocarti-
lage was mature and organized, which suggested recupera-
tion of the original meniscus morphology, with type I
collagen fibers arranged in parallel and fibrochondrocytes im-
mersed in the matrix (Fig. 5G). In three of five cases, small for-
eign body granulomas were seen in contiguity with the
normal lateral synovial membrane in peripheral areas. Meta-
chromasia was present in all animals examined (Fig. 5H). The
condyles contained chondrocytes and the extracellular matrix
was organized and evenly distributed in all layers (Fig. 5I).
Control rabbits showed the presence of fat and fibrosis in
small fibrocartilage-like areas at the periphery (Fig. 5J), as
well as the formation of central hyaline cartilage during
wound healing (Fig. 5K). The control condyle contained chon-
drocytes irregularly distributed in the matrix with obvious
signs of loss and matrix degeneration (Fig. 5L) and in some
areas the presence of fibrous tissue along the upper were
also observed.
Histomorphometry
Figure 6 shows the average number of chondrocytes per
field in each of the experimental groups studied. Twelve
and 24 weeks after the implant, all groups showed signifi-
cantly more cells in the extracellular than the negative control
( p < 0.01). There was no significant difference between cell-
free and cell-seeded scaffolds, and both of these were similar
to the normal condyle (positive control; p > 0.05).
Discussion
The current challenge for tissue engineering is to develop
devices capable of interacting with body tissues to stimulate
regeneration. Even though advances in the development of
novel artificial matrices have beenmade, attempts to engineer
cartilaginous tissues, such as meniscus and articular cartilage,
have led to tissue with mechanical properties and biological/
biochemical features different from to those of the native tis-
sue.34
The compressive mechanical properties of the PLDLA/
PCL-T scaffolds were found to be better than those of the pol-
yglycolic acid (PGA) scaffolds mechanically stabilized by
bonding adjacent PGA fibers with PLGA that were proposed
for meniscus regeneration.35 Furthermore, PLDLA/PCL-T
scaffolds have a compressive modulus (9.5 – 1.0MPa) that
falls in the range of those reported for macro/microporous
silk fibroin scaffolds that were proposed to be suitable for ar-
ticular cartilage and meniscus tissue engineering applica-
tions. Specifically, the dry state compressive modulus of the
above mentioned scaffolds increased from 0.81 – 0.29 to
15.14– 1.70MPa, depending upon the silk fibroin concentra-
tion.36
Surgical intervention always results in mechanical trauma.
The tissue response to such aggression begins with inflamma-
tion and proceeds through the healing steps. In the presence
of an implant, there may also be a ‘‘foreign body reaction’’ in
response to the recognition of foreign material in the host.37
With regard to this study, although the foreign body granulo-
matous response is commonly observed with implants, its oc-
currence has no major significance on the neoformation of
fibrocartilage. Many studies have shown that bioreabsorbable
polymers based on poly (a-hydroxy acids), which are widely
used for tissue regeneration, produce similar foreign body in-
flammatory reactions that usually disappear after complete
polymer degradation12–14,18,38–39 as occurred in this case.
When amenable, the regeneration of the meniscus is ini-
tially characterized by the formation of vascularized fibrous
tissue that differentiates into phenotypically fibrocartilage-
nous tissue after a few months.40
The results described here regarding the control defect
agreed with the findings of others showing that rabbit me-
nisci have no intrinsic recovery response and are only capable
of forming fibrous cicatrization tissue.33,41–43 Likewise, when
injured in the inner and middle portions, the human menis-
cus does not undergo spontaneous regeneration and there
are currently no surgical methods to promote this.12 This lim-
itation is also related to the low vascularization of this tissue.
The presence of hyaline cartilage in the inner portion of
newly formed tissue of the control defect was also observed
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in rabbits by Kang et al.35 Their results indicated a greater
amount of type II collagen in the inner portion of the menis-
cus (a feature of hyaline cartilage), while the outer zone of the
new tissue was fibrous and consisted almost entirely of type I
collagen.
The limited capacity of meniscal tissue for regeneration
and the fact that fibrocartilage injuries usually result in
slow, difficult cicatrization make tissue-engineering tech-
niques a promising alternative for repairing injured menisci
in order to preserve tissue functions and prevent degenera-
tive joint diseases.44 The construction and maintenance of
an appropriate interface for the formation of fibrocartilagi-
nous tissue is therefore critical for the successful use of
implants in tissue engineering, particularly since this
FIG. 5. Twenty-four weeks after implantation. Scale bar = 100lmunless otherwise indicated. (A–C) Photomicrograph of nor-
mal rabbit medial meniscus and condyle. (A) The horn (tip) of the meniscus consisted mainly of thin circumferentially oriented
collagen fibers and a few elongated cells; HE. (B) Central region of the meniscus showing numerous round fibrochondrocytes
surrounded by collagen fibers; HE. (C) A normal femoral condyle (positive control) showing the organization of the extracel-
lular matrix and the presence of chondrocytes throughout the cartilage; HE, , scale bar= 200 lm. (D–F) Photomicrographs of
knee joints after receiving cell-free implants. (D) Fibrocartilage-like tissue with disorganized cells and irregularly arranged col-
lagen fibers; MT. (E) Fibrocartilage-like metachromatic tissue; TB. (F)A femoral condyle showing the arrangement of chondro-
cytes; HE. (G–I) Photomicrographs of knee joints after receiving cell-seeded implants. (G) Mature fibrocartilage-like tissue.
Parallel arrangement of type I collagen fibers and fibrochondrocytes distributed throughout the matrix; MT, scale bar = 50 lm.
(H) Fibrocartilage-like metachromasia; TB, scale bar = 50 lm. (I) A femoral condyle with a large number of chondrocytes at the
periphery; HE. ( J–L) Photomicrographs of control knee joints (empty defect) 24 weeks after total medial meniscectomy. ( J) The
presence of a large amount of adipose tissue and fibrosis (arrow); HE. (K) Central hyaline cartilage; MT. (L) A femoral condyle
showing the irregular arrangement of cells; HE, scale bar = 200lm.
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approach involves the proliferation of viable cells on bioma-
terial substrates.
Scaffold porosity is an important feature that can facilitate
the formation of meniscus fibrocartilage-like tissue.45,46 Fur-
thermore, the time required for fibrocartilage formation
should be considered when selecting the appropriate material
since scaffolds are incubated with cells in liquid culture me-
dium prior to use and degradation may therefore begin be-
fore implantation. Elema et al.47 reported that
fibrocartilaginous formation in humans requires approxima-
tely 20 weeks, a rather long period. Recently, preseeded scaf-
folds have been used to enhance healing during meniscus
regeneration.19,21–23,33,48
Weinand et al.22 examined the use of autologous and allo-
geneic chondrocytes, cultured with commercial bioreabsorb-
able PLGA scaffolds (Vicryl, Ethicon Inc.) and later used
as implants. Their results indicated that preseeding the scaf-
folds promoted lesion regeneration in an avascular meniscal
region in pigs. Fluorescent staining of these precultured
cells demonstrated their presence in neotissue that integrated
with the native meniscus after 12 weeks. There was no lym-
phocytic infiltration (which would have been indicative of
cellular rejection) and no significant difference in the repair
obtained with autologous and allogeneic cultures.
Kang et al.35 have also evaluated meniscus regeneration in
rabbit meniscus with total medial meniscectomy. They used a
porous PLGA structure reinforced with PGA fibers and pre-
seeded with meniscus cells. Their results indicated the forma-
tion of fibrocartilage-like tissue with similar histological
features to those of normal meniscus. However, histological
analysis of the adjacent tibial articular cartilage showed that
the neomeniscus did not prevent the degeneration of articular
cartilage after 36 weeks.
Regarding the cell type selected as cell source in this study
Figueiredo49 demonstrated the feasibility of culturing fibro-
chondrocytes. These cells can be reproducibly isolated from
fibrocartilage and maintain their phenotypic characteristics
(cell properties and extracellular matrix synthesis) in culture.
Araujo50 showed that fibrocartilage cells cultured in vitro do
not lose their intrinsic ability to initiate a repair response
when directly seeded onto substrates. Moreover, we have
previously shown that a PLDLA/PCL-T 90/10 scaffold pro-
vides a suitable substrate for the growth of rabbit fibrocartila-
ginous cells in vitro; the cells proliferated and infiltrated the
scaffold, creating a three-dimensional arrangement.51
The results described here for 12 weeks after implantation
showed that, regardless of whether they had been preseeded
with cells, the PLDLA/PCL-T scaffolds produced amuch bet-
ter response than the control group (empty defect). At this
time interval, there was no significant qualitative difference
in the production of fibrocartilage-like tissue by scaffolds
with or without cells. Twenty-four weeks after implantation
the ‘‘neomeniscus’’ was more organized than the fibrocartila-
ginous tissue seen after 12 weeks. Mature fibrocartilage with
organized fibers was seen after 24 weeks, primarily with im-
plants precultured with allogeneic fibrochondrocytes. This
was confirmed by staining with HE and MT, which showed
type I collagen fibers arranged circumferentially in the extra-
cellular matrix of the neomenisci, as also occurs in the normal
meniscus. The presence of sulfated glycosaminoglycans in
neotissue was also an important parameter for assessing re-
generation.
In this study, there was no direct immune response during
the regeneration of meniscus tissue with allogeneic cells when
compared to cell-free implants. This finding agrees with stud-
ies that have reported no immune rejection with allogeneic
cells22,23,35 or with cryopreserved menisci for transplants.52
The decision to use allogeneic cells in this study reflected
the ease with which allogeneic meniscal fibrochondrocytes
can be obtained since these cells are more accessible than au-
tologous cells for transplants. In addition, performing a bi-
opsy to obtain cells would generate a cicatrization response
that would reduce tissue regeneration after the surgery re-
quired for scaffold implantation. A biopsy would also yield
a lower number of cells and this would in turn require
weeks of culture to allow sufficient expansion of the cell pop-
ulation for later seeding.23
Another important aspect that has to be considered is
whether or not the meniscus engineered construct presents
any consequencewithin the articular cartilage. In knees submit-
ted to meniscectomy the contact area can be reduced by ap-
proximately 50%.53 This loss of area increases the load per
unit area in articular cartilage and results in damage and carti-
lage degeneration, causing arthritis, osteoarthritis, and pain.54
The degree of osteoarthritis after meniscectomy is directly pro-
portional to the amount of meniscus removed.55 Truly, the
main aim of using polymeric scaffolds for tissue regeneration
is to replace the lost or damaged meniscus, thereby avoiding
severe medium and long-term injury to the articular cartilage.
Histomorphometric analysis indicated that the knee joint
cartilage was preserved by the polymeric implants. This pro-
tection was reflected in the higher percentage of chondrocytes
in rabbits treated with polymeric scaffolds and in the positive
controls when compared with the negative controls, which
showed cellular disarray (indicative of degenerative osteoar-
thritis) after 12 and 24 weeks.
Most recently, similar results were found by Kon et al.56
showing that osteoarthritic changes were significantly less
in the cell-seeded group than in the meniscectomy group,
FIG. 6. The average number of chondrocytes per micro-
scopic field in each of the groups studied. The columns repre-
sent the mean– SD. All groups showed significantly more
cells in the extracellular than the negative control ( p < 0.01).
Assessment data showed negligible joint degeneration in
the positive control (normal condyle). Rabbits treated with
cell-free and cell-seeded scaffold implantation achieved simi-
lar results to the normal condyle group ( p> 0.05). No signifi-
cant difference between cell-free and cell-seeded scaffolds
was found ( p > 0.05).
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even though results were not significantly superior to those of
the cell-free scaffold. Additionally the study confirms the role
of cells for increasing the tissue regeneration capacity, provid-
ing a better fibrocartilaginous tissue formation. These results
supported by the results presented in this paper and the liter-
ature suggest the potential of bioresorbable scaffolds and tis-
sue engineering approach for total meniscal substitution.
Finally, although the scaffolds and protocols used here
resulted in quicker fibrocartilage formation compared to pre-
vious studies, these findings need to be confirmed by immu-
nological analyses and longer post-implantation intervals.
Despite the limitations of this study, the results described
here demonstrate that regeneration of the meniscus, an im-
portant fibrocartilaginous structure, can be achieved using
bioreabsorbable polymer scaffolds and allogeneic cells.
In conclusion, the PLDLA/PCL-T 90/10 polymeric scaf-
fold has potential for biomedical applications since this mate-
rial allowed the formation of fibrocartilaginous tissue, a
structure of crucial importance for repairing injuries to joints,
including replacement of the meniscus and the protection of
articular cartilage from degeneration.
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